Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing-Reference-Cited by-同舟云学术

Impact of Cytidine Deaminase Polymorphisms on Toxicity After Gemcitabine: The Question Is Still Ongoing

Published:2010-05-10 Issue:14 Volume:28 Page:e221-e222
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Giovannetti Elisa¹,Tibaldi Carmelo²,Falcone Alfredo³,Danesi Romano⁴,Peters Godefridus J.⁵

Affiliation:

1. Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands; and Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of Pisa, Pisa, Italy

2. Division of Oncology, Department of Oncology, Azienda USL-6 of Livorno

3. Division of Oncology, Department of Oncology, Azienda USL-6 of Livorno; and the University of Pisa, Istituto Tumori Toscano, Italy

4. Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of Pisa, Pisa, Italy

5. Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.27.4928

Reference10 articles.

1. Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies

2. Drug resistance to 5-aza-2 ′ -deoxycytidine, 2 ′ ,2 ′ -difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells

3. Clinical pharmacology and pharmacogenetics of gemcitabine

4. Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

5. Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung Cancer;Anticancer Research;2020-02

2. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine;Blood Advances;2018-02-28

3. Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective;Cancer Chemotherapy and Pharmacology;2016-03-23

4. Yin and yang of cytidine deaminase roles in clinical response to azacitidine in the elderly: a pharmacogenetics tale;Pharmacogenomics;2015-11

5. Pharmacogenetics and breast cancer management: current status and perspectives;Expert Opinion on Drug Metabolism & Toxicology;2015-02-18